USA - NYSEARCA:ELMD - US2854091087 - Common Stock
The current stock price of ELMD is 26.51 USD. In the past month the price increased by 1.6%. In the past year, price decreased by -11.91%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.94 | 225.29B | ||
| ISRG | INTUITIVE SURGICAL INC | 66.11 | 204.06B | ||
| BSX | BOSTON SCIENTIFIC CORP | 35.79 | 156.45B | ||
| SYK | STRYKER CORP | 28.5 | 143.48B | ||
| IDXX | IDEXX LABORATORIES INC | 55.84 | 56.33B | ||
| BDX | BECTON DICKINSON AND CO | 13.42 | 55.47B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.11 | 49.95B | ||
| RMD | RESMED INC | 25.58 | 36.97B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.41 | 34.39B | ||
| PODD | INSULET CORP | 72.87 | 23.44B | ||
| DXCM | DEXCOM INC | 32.22 | 23.50B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.25 | 18.03B |
Electromed, Inc. engages in the development, manufacture, marketing, and sale of medical equipment. The company is headquartered in New Prague, Minnesota and currently employs 177 full-time employees. The company went IPO on 2010-08-13. The company applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. The company also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
ELECTROMED INC
500 Sixth Avenue Nw
New Prague MINNESOTA 56071 US
CEO: Kathleen S. Skarvan
Employees: 174
Phone: 19527589299
Electromed, Inc. engages in the development, manufacture, marketing, and sale of medical equipment. The company is headquartered in New Prague, Minnesota and currently employs 177 full-time employees. The company went IPO on 2010-08-13. The company applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. The company also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
The current stock price of ELMD is 26.51 USD. The price increased by 4.45% in the last trading session.
ELMD does not pay a dividend.
ELMD has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
ELMD stock is listed on the NYSE Arca exchange.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ELMD.
ELECTROMED INC (ELMD) currently has 174 employees.
ChartMill assigns a technical rating of 7 / 10 to ELMD. When comparing the yearly performance of all stocks, ELMD is one of the better performing stocks in the market, outperforming 70.71% of all stocks.
ChartMill assigns a fundamental rating of 7 / 10 to ELMD. ELMD gets an excellent profitability rating and is at the same time showing great financial health properties.
Over the last trailing twelve months ELMD reported a non-GAAP Earnings per Share(EPS) of 0.93. The EPS increased by 29.17% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 11.78% | ||
| ROA | 14.01% | ||
| ROE | 17.44% | ||
| Debt/Equity | 0 |
10 analysts have analysed ELMD and the average price target is 35.7 USD. This implies a price increase of 34.67% is expected in the next year compared to the current price of 26.51.
For the next year, analysts expect an EPS growth of 20.21% and a revenue growth 13.69% for ELMD